News in Numbers

In 2024, the FDA approved 50 novel drugs that contained an active ingredient not previously approved by the agency, whilst the EMA authorised 46 new medicines.

The total prevalence of Alzheimer’s cases in the eight major markets will reach an estimated 22.51 million by 2033, as per GlobalData analysis. 

Meridian Medical Technologies has won a new contract worth up to $129m from the US Government for the supply of its DuoDote chemical nerve agent antidote autoinjectors to the Strategic National Stockpile (SNS).

CRISPR biotech Intellia Therapeutics has announced plans to reduce its workforce by 27% and halt early-stage R&D programmes as it concentrates resources on two late-stage drug candidates.

Eight people have likely died from an outbreak of Marburg virus disease (MVD) in a northwestern region of Tanzania, according to the World Health Organization (WHO).